Haegarda
C1 Esterase Inhibitor (Human)
Approved to treat Hereditary Angioedema (HAE) attacks in adolescent and adult patients.
Report side effects/adverse events at 1-866-915-6958.
Ruconest
C1 Esterase Inhibitor (Recombinant)
Approved to treat acute attacks in adult and adolescent patients with Hereditary Angioedema (HAE).
Report side effects/adverse events at 1-800-508-0024.
Cinryze
C1 Esterase Inhibitor (Human)
Approved to treat against angioedema attacks in patients with Hereditary Angioedema (HAE).
Report side effects/adverse events at 1-877-825-3327.
Newest NAC members bring geriatric and pediatric expertise
July 15, 2025
Read article
Statement on H.R. 1: Medicaid cuts threaten vulnerable patients
July 09, 2025
Read statement
Octapharma Plasma
The family-owned company, Octapharma AG, was established in 1983 with a single idea: that people with Hemophilia deserve access to better treatments.
Jerry Winkelstein helped build IDF’s respected reputation
July 02, 2025
Read article
Foundation Focus: June 2025 update with CEO Jorey Berry
June 30, 2025
Listen to podcast
Financial assistance programs can help with medical bills
June 25, 2025
Read article
Grandpa Gagen's journey to platelet donation
June 24, 2025
Read article
